Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of the Urea Cycle”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Study completedNCT01347073
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)

Who this might be right for
Urea Cycle Disorders
Amgen 23
Early research (Phase 1)Study completedNCT04442347
What this trial is testing

Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency

Who this might be right for
Ornithine Transcarbamylase Deficiency
Arcturus Therapeutics, Inc. 16
Not applicableStudy completedNCT03911089
What this trial is testing

A Collection of Case Studies in Infants With UCD to Evaluate Infant Growth and the Safety of a New Medical Food for UCD

Who this might be right for
Urea Cycle DisorderInborn Errors of Metabolism
Nutricia Research 3
Testing effectiveness (Phase 2)Looking for participantsNCT06488313
What this trial is testing

Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

Who this might be right for
OTC DeficiencyOrnithine Transcarbamylase DeficiencyOTCD
Arcturus Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT05526066
What this trial is testing

Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810

Who this might be right for
Ornithine Transcarbamylase DeficiencyOTC DeficiencyOTCD
Arcturus Therapeutics, Inc. 8
Not applicableLooking for participantsNCT02132741
What this trial is testing

Optical Coherence Tomography And NEphropathy: The OCTANE Study

Who this might be right for
HealthHypertensionChronic Kidney Disease
University of Edinburgh 150
Large-scale testing (Phase 3)Study completedNCT00947297
What this trial is testing

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

Who this might be right for
Urea Cycle Disorders
Amgen 60
Not applicableStudy completedNCT01080859
What this trial is testing

Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography

Who this might be right for
Acute Coronary Syndrome
The Hospital District of Satakunta 40
Testing effectiveness (Phase 2)Study completedNCT01599286
What this trial is testing

Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia

Who this might be right for
Propionic Acidemia, Type I and/or Type IIMethylmalonic AcidemiaCarbamoyl-Phosphate Synthase I Deficiency Disease+1 more
Mendel Tuchman 35
Testing effectiveness (Phase 2)WithdrawnNCT01791192
What this trial is testing

Study of FTY720 in Patients With Uveitis

Who this might be right for
Acute Noninfectious Posterior, Intermediate, or Pan Uveitis
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01742507
What this trial is testing

A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study

Who this might be right for
Coronary Artery Disease
The University of Hong Kong 60
Testing effectiveness (Phase 2)Study completedNCT02488044
What this trial is testing

AEB1102 in Patients With Arginase I Deficiency

Who this might be right for
Arginase I DeficiencyHyperargininemia
Aeglea Biotherapeutics 16
Large-scale testing (Phase 3)Study completedNCT03921541
What this trial is testing

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Who this might be right for
Arginase I DeficiencyHyperargininemia
Immedica Pharma AB 32
Early research (Phase 1)Study completedNCT04416126
What this trial is testing

Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects

Who this might be right for
Ornithine Transcarbamylase Deficiency
Arcturus Therapeutics, Inc. 30
Not applicableStudy completedNCT03323307
What this trial is testing

Low Cost OCT for Point of Care

Who this might be right for
Optical Coherence Tomography (OCT) of the Retina
Duke University 70
Post-approval studies (Phase 4)Study completedNCT01257737
What this trial is testing

To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)

Who this might be right for
Urea Cycle Disorders
Amgen 88
Not applicableStudy completedNCT07074041
What this trial is testing

Radiomic Analysis in OCT Imaging of Acquired Vitelliform Lesions.

Who this might be right for
VITELLIFORM LESIONS
Federico II University 50
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Next Page